Anti-HER2 Therapy in Elderly Breast Cancer Patients

Author(s): Masataka Sawaki

Journal Name: Reviews on Recent Clinical Trials

Volume 9 , Issue 4 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Targeting anti-HER-2 therapy, trastuzumab, Lapatinib, T-DM1, and Pertuzumab is a standard therapy for HER-2-overexpressing breast cancer. But there are less data available related to anti-HER-2 therapy in elderly patients because they have been consistently underrepresented in clinical trials. Anti- HER-2 therapy among an elderly population was reviewed including approaches for making treatment effective.

Keywords: Anti-HER2 therapy, breast cancer, HER-2/neu, elderly.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [263 - 266]
Pages: 4
DOI: 10.2174/1574887109666141127102035
Price: $65

Article Metrics

PDF: 55